Diagnostic performance of four lateral flow immunoassays for COVID-19 antibodies in Peruvian population
Description
Serological assays have been used in seroprevalence studies to inform the dynamics of COVID-19. Lateral flow immunoassay (LFIA) tests are a very practical technology to use for this objective; however, one of their challenges may be variable
